Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
-
NEW YORK and MIAMI, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Biz2X®, a global fintech small business finance platform headquartered in New York that has facilitated over $10 billion in SMB funding to...
-
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
CG Oncology Announces Proposed Public Offering
-
CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Thursday, December 5, 2024
-
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab
-
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
-
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
-
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024